Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Susceptibility of acinetobacter strains isolated from deployed U.S. military personnel.

Literature DB >> 17043112

Susceptibility of acinetobacter strains isolated from deployed U.S. military personnel.

Joshua S Hawley¹, Clinton K Murray, Matthew E Griffith, M Leticia McElmeel, Letitia C Fulcher, Duane R Hospenthal, James H Jorgensen.

Abstract

The susceptibilities of 142 Acinetobacter baumannii-calcoaceticus complex isolates (95 from wounded U.S. soldiers deployed overseas) to 13 antimicrobial agents were determined by broth microdilution. The most active antimicrobial agents (> or =95% of isolates susceptible) were colistin, polymyxin B, and minocycline.

Entities: Chemical Species

Mesh：

Substances：

Year: 2006 PMID： 17043112 PMCID： PMC1797659 DOI： 10.1128/AAC.00858-06

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

10 in total

1. Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii.

Authors: Jian Li; Craig R Rayner; Roger L Nation; Roxanne J Owen; Denis Spelman; Kar Eng Tan; Lisa Liolios
Journal: Antimicrob Agents Chemother Date: 2006-09 Impact factor: 5.191

Review 2. Tigecycline.

Authors: James E Frampton; Monique P Curran
Journal: Drugs Date: 2005 Impact factor: 9.546

Review 3. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America.

Authors: George H Talbot; John Bradley; John E Edwards; David Gilbert; Michael Scheld; John G Bartlett
Journal: Clin Infect Dis Date: 2005-01-25 Impact factor: 9.079

4. Acinetobacter skin colonization of US Army Soldiers.

Authors: Matthew E Griffith; Julia M Ceremuga; Michael W Ellis; Charles H Guymon; Duane R Hospenthal; Clinton K Murray
Journal: Infect Control Hosp Epidemiol Date: 2006-06-12 Impact factor: 3.254

Review 5. Treatment of multidrug resistant Acinetobacter.

Authors: Clinton K Murray; Duane R Hospenthal
Journal: Curr Opin Infect Dis Date: 2005-12 Impact factor: 4.915

6. In vitro activities of tigecycline, ertapenem, isepamicin, and other antimicrobial agents against clinically isolated organisms in Taiwan.

Authors: Nai-Cheng Cheng; Po-Ren Hsueh; Yung-Ching Liu; Jainn-Ming Shyr; Wen-Kuei Huang; Lee-Jene Teng; Cheng-Yi Liu
Journal: Microb Drug Resist Date: 2005 Impact factor: 3.431

7. Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001.

Authors: James A Karlowsky; Deborah C Draghi; Mark E Jones; Clyde Thornsberry; Ian R Friedland; Daniel F Sahm
Journal: Antimicrob Agents Chemother Date: 2003-05 Impact factor: 5.191

8. Antimicrobial susceptibility testing of Acinetobacter spp. by NCCLS broth microdilution and disk diffusion methods.

Authors: Jana M Swenson; George E Killgore; Fred C Tenover
Journal: J Clin Microbiol Date: 2004-11 Impact factor: 5.948

Review 9. Acinetobacter outbreaks, 1977-2000.

Authors: Maria Virginia Villegas; Alan I Hartstein
Journal: Infect Control Hosp Epidemiol Date: 2003-04 Impact factor: 3.254

10. Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004.

Authors:
Journal: MMWR Morb Mortal Wkly Rep Date: 2004-11-19 Impact factor: 17.586

10 in total

38 in total

1. In vitro characterization of multivalent adhesion molecule 7-based inhibition of multidrug-resistant bacteria isolated from wounded military personnel.

Authors: Anne Marie Krachler; Katrin Mende; Clinton Murray; Kim Orth
Journal: Virulence Date: 2012-06-22 Impact factor: 5.882

2. Personalized Therapeutic Cocktail of Wild Environmental Phages Rescues Mice from Acinetobacter baumannii Wound Infections.

Authors: James M Regeimbal; Anna C Jacobs; Brendan W Corey; Matthew S Henry; Mitchell G Thompson; Rebecca L Pavlicek; Javier Quinones; Ryan M Hannah; Meron Ghebremedhin; Nicole J Crane; Daniel V Zurawski; Nimfa C Teneza-Mora; Biswajit Biswas; Eric R Hall
Journal: Antimicrob Agents Chemother Date: 2016-09-23 Impact factor: 5.191

3. In-silico modeling of a novel OXA-51 from β-lactam-resistant Acinetobacter baumannii and its interaction with various antibiotics.

Authors: Vishvanath Tiwari; Isha Nagpal; Naidu Subbarao; Rajeswari R Moganty
Journal: J Mol Model Date: 2012-01-22 Impact factor: 1.810

4. Pharmacodynamics of Minocycline against Acinetobacter baumannii in a Rat Pneumonia Model.

Authors: Ziad Tarazi; Mojgan Sabet; Michael N Dudley; David C Griffith
Journal: Antimicrob Agents Chemother Date: 2019-01-29 Impact factor: 5.191

Review 5. Acinetobacter pneumonia: a review.

Authors: Joshua D Hartzell; Andrew S Kim; Mark G Kortepeter; Kimberly A Moran
Journal: MedGenMed Date: 2007-07-05

6. Activity of meropenem with and without ciprofloxacin and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii.

Authors: Glenn A Pankuch; Gengrong Lin; Harald Seifert; Peter C Appelbaum
Journal: Antimicrob Agents Chemother Date: 2007-10-29 Impact factor: 5.191